chr14-60648817-C-T
Variant summary
Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_005982.4(SIX1):c.373G>A(p.Glu125Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005982.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 15 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SIX1 | NM_005982.4 | c.373G>A | p.Glu125Lys | missense_variant | Exon 1 of 2 | ENST00000645694.3 | NP_005973.1 | |
| SIX1 | NM_001425142.1 | c.373G>A | p.Glu125Lys | missense_variant | Exon 1 of 2 | NP_001412071.1 | ||
| MIR9718 | NR_162089.1 | n.*106C>T | downstream_gene_variant | |||||
| MIR9718 | unassigned_transcript_2330 | n.*117C>T | downstream_gene_variant |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SIX1 | ENST00000645694.3 | c.373G>A | p.Glu125Lys | missense_variant | Exon 1 of 2 | NM_005982.4 | ENSP00000494686.1 | |||
| SIX1 | ENST00000554986.2 | c.42-2240G>A | intron_variant | Intron 1 of 1 | 3 | ENSP00000452700.2 | ||||
| SIX1 | ENST00000553535.2 | n.249-2240G>A | intron_variant | Intron 2 of 2 | 3 | |||||
| SIX1 | ENST00000555955.3 | n.1198-2240G>A | intron_variant | Intron 1 of 1 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 23 Pathogenic:2
The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.79; 3Cnet: 0.98). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SIX1 related disorder (ClinVar ID: VCV000208361 / PMID: 21700001).The variant has been reported to co-segregate with the disease in at least 5 similarly affected relatives/individuals in the same family or similarly affected unrelated families (PMID: 21700001). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
Branchiootic syndrome 3 Pathogenic:1Other:1
- -
- -
Branchiootic syndrome 3;C1854594:Autosomal dominant nonsyndromic hearing loss 23 Pathogenic:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 125 of the SIX1 protein (p.Glu125Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of SIX1-related conditions (PMID: 21700001, 37479820). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 208361). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SIX1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SIX1 function (PMID: 37479820). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at